Form D · Other

Lyra Health, Inc.

Burlingame, CA · CIK 0001733914

Offering snapshot reported Jan 19, 2022 · SEC filing

Reported sold
$235M
Offering amount: $235M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 7, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 19, 2022Initial$234,999,956No comparison4SEC filing
Jun 15, 2021Initial$199,999,931No comparisonNot reportedSEC filing
Jan 28, 2021Initial$186,689,404No comparison33SEC filing
Aug 25, 2020Initial$109,999,815No comparison23SEC filing
Mar 11, 2020Initial$74,999,973No comparison19SEC filing
Dec 17, 2018Amendment$61,029,561$16,279,545vs Jun 25, 201819SEC filing
Jun 25, 2018Initial$44,750,016No comparison19SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-429972

Source: Form D, filed Jan 19, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lisa Caccavo Executive
Kerry Chandler Director
Somesh Das Director
Somesh Dash Director
David Ebersman Director, Executive
Danielle Gray Director
Bob Kocher Director
Hubert Lin Executive
Bryan Roberts Director
Robynne Sisco Director
James Slavet Director
Elaine Yang Executive

Issuer details

Industry: Other (See others in industry)

Address:
287 Lorton Avenue
Burlingame, CA, 94010